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It is interesting to read this number, given the fact that the statistics reported by recent graduates show that closer to 50% of their colorectal operations were laparoscopically undertaken. 7 The main reason for this large discrepancy in this retrospective data sample versus the prospective data collection by graduating general and colorectal surgical residents is clearly stated by the authors in both their Methods and Discussion sections. ''Because there were no specific codes to identify laparoscopic colonic prior to 2008, colonic resections were defined as minimally invasive if the ICD-9-CM procedure code for laparoscopy (54.21) was identified among the primary procedures in addition to a code for colectomy. All other colectomies were considered open'' I believe that this methodology is flawed in that many surgeons would have been fearful of ''unbundling'' and adding a laparoscopic code to a colectomy procedure.
Accordingly, the potential for significant undercoding could have easily led to what the authors quite appropriately state in their discussion-specifically that this methodology ''may have resulted in an under estimation of laparoscopic cases for colon cancer resection.'' Therefore, not only might the adoption rate have been higher, but all of the results may have been different if more of the laparoscopically performed procedures had been coded in that manner and thus included for data analysis within the laparoscopic group. There are some other, perhaps less major issues in the study, such as, as the authors also note, failure to collect body mass index data for comparison between the two groups. Moreover, features such as tumor size and location are not included, nor are potentially relevant issues in the discussion-making process, such as prior laparotomy. Unfortunately, the definition of a teaching hospital is not provided, nor are definitions offered for the Table 2 headings of bed size ''small'' versus ''medium'' versus ''large.'' The authors found a reference to define a ''high-volume'' colon surgeon as someone who performs just over one procedure per month, with a reported median actually being only one case slightly less than 6 weeks. Specifically, they defined a high-volume colon surgeon as someone who performs at least 15 cases annually. I would consider this number to be unacceptably low to qualify as high volume, and urge the authors to consider other data sources to set their definition of a high-volume colon and rectal surgeon. [8] [9] [10] [11] [12] The authors should reconsider the definition, which may greatly alter the results of their univariate and multivariate analyses. It has been well demonstrated within the rectal cancer literature that outcomes are indeed related to surgical volume, but the highvolume numbers must be indeed truly high volume. [8] [9] [10] [11] [12] [13] [14] Another factor of this study to be considered is that the authors do correctly reference publications that cite the learning curve for laparoscopic colorectal resection as ranging from 30 to 70 cases. [15] [16] [17] [18] However, the authors do not account for the fact that general and colorectal surgical residents, and perhaps surgical oncology and minimally invasive surgical trainees, may easily perform this requisite number during training. The authors do not detail the potential effects of cases performed during training, nor do they mention the more recently widely available training methods of simulation. 19, 20 The shortcomings of this article may be easily overcome when these authors or other investigators next analyze these data because laparoscopic colectomy codes have been in existence for the last several years. I suspect that we will see adoption in at least 30% of cases, if not closer to 60%, at least for colon resections. The last frontier of laparoscopic colorectal surgery is proctectomy for cancer. Although this procedure may be performed by numerous individuals in an ''off-label'' setting, the American College of Surgeons Oncology Group Z6051 randomized, controlled trial lead by Dr. James Fleshman will, I hope, soon lead us to a data-driven answer. 21 Similarly, the COLOR2 trial has been designed to assess the safety and feasibility of laparoscopic proctectomy for cancer. 22 
